Deepti Dwivedi, Shubham Pandey, Shafaque Asif, Vineet Awasthi, Gurjeet Kaur, Nimisha
Deepti Dwivedi1, Shubham Pandey1, Shafaque Asif2, Vineet Awasthi2, Gurjeet Kaur2, Nimisha*1
1Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Sector 125, Noida, 201313, India.
2 Amity Institute of Biotechnology, Lucknow, Amity University Uttar Pradesh, Sector 125, Noida, 201313, India.
Volume - 14,
Issue - 12,
Year - 2021
Objective: The present research work was undertaken to develop quercetin enthused nanolipoidal systems and its characterization. The objective was to investigate potential of prepared system in the management of DNCB induced dermatitis. Method: Nanolipoidal system was prepared in different combinations with quercetin, L-a phosphatidylcholine (SPC) and ethanol and characterized for particle size, polydispersity index (PDI), zeta potential, drug entrapment efficiency, percentage drug release, skin retention and skin permeation. Selected batches were further incorporated into Carbopol 934 base gel. The vesicles were in size range 324.19-359 nm while polydispersity index (PDI) ranges from 0.241-0.554 and for zeta potential, it was from -26.33 to -39.3 nm. Entrapment efficiency was from 23.77-94.68 %. Confocal laser scanning microscopy showed penetration depth of rhodamine enthused ethosome across rat skin up to 45.23 µm which was significantly higher than the rhodamine solution (10 µm). In dinitrochlorobenzene (DNCB) induced mice dermatitis model histopathology study showed a marked decrease in amount of inflammatory cell nucleus in mice treated with quercetin loaded ethosomal gel followed by 76.13% decrease in-ear swelling and ear mass respectively in morphology study. The conventional marketed formulation showed a nominal decrease in epidermal thickness. Further Primary irritation index was less than 0.4 indicating negligible irritation in all the groups. Results: The optimized formulation F6 with SPC and ethanol in the ratio of 20:80 displayed the highest drug content and entrapment efficiency of 94.68±1.14%. PDI was 0.241±0.11 and skin retention 7.7%. Batch F6 with vesicle size and zeta potential of 324.9±19 nm and -26.33 mV, respectively, was incorporated in Carbopol 934 base gel and the prepared gel was evaluated for morphology, spreadability, in vitro, ex vivo release study, and kinetics study and in vivo studies. Conclusion: The present study revealed that the developed ethosomal gel can be used for enhanced delivery of Quercetin via skin. The in vitro studies indicated that the gel serves as an efficient carrier for Quercetin. It showed its effectiveness in the management of dermatitis. Further, Quercetin loaded nanoethosomal gel formulation can be viewed as a promising drug delivery system for the management of dermatitis.
Cite this article:
Deepti Dwivedi, Shubham Pandey, Shafaque Asif, Vineet Awasthi, Gurjeet Kaur, Nimisha. Investigating the potential of Quercetin enthused nano lipoidal system for the management of dermatitis. Research Journal of Pharmacy and Technology. 2021; 14(12):6516-6. doi: 10.52711/0974-360X.2021.01127
Deepti Dwivedi, Shubham Pandey, Shafaque Asif, Vineet Awasthi, Gurjeet Kaur, Nimisha. Investigating the potential of Quercetin enthused nano lipoidal system for the management of dermatitis. Research Journal of Pharmacy and Technology. 2021; 14(12):6516-6. doi: 10.52711/0974-360X.2021.01127 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-12-57
1. Marks JG, Miller JJ. Lookingbill and Marks' Principles of Dermatology E-Book. Elsevier Health Sciences; 2017 Dec 22.
2. Souto EB, Dias-Ferreira J, Oliveira J, Sanchez-Lopez E, Lopez-Machado A, Espina M, Garcia ML, Souto SB, Martins-Gomes C, Silva AM. Trends in Atopic Dermatitis—From Standard Pharmacotherapy to Novel Drug Delivery Systems. International journal of molecular sciences. 2019 Jan; 20(22):5659.
3. Tsakok T, Woolf R, Smith CH, Weidinger S, Floh C. Atopic dermatitis: the skin barrier and beyond. British Journal of Dermatology. 2019 Mar;180(3):464-74.
4. Frazier W, Bhardwaj N. Atopic Dermatitis: Diagnosis and Treatment. American family physician. 2020 May 15;101(10):590-8.
5. Pandey V, Golhani D, Shukla R. Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug delivery. 2015 Nov 17;22(8):988-1002.
6. El-Menshawe SF, Sayed OM, Abou-Taleb HA, El Tellawy N. Skin permeation enhancement of nicotinamide though using fluidization and deformability of positively charged ethosomal vesicles: A new approach for treatment of atopic eczema. Journal of Drug Delivery Science and Technology. 2019 Aug 1;52:687-701.
7. Fatima Z. Formulation and performance evaluation of Berberis aristata extract loaded ethosomal gel. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm. 2017 Sep 9;11(03).
8. Nimisha, Rizvi DA, Fatima Z, Neema, Kaur CD. Antipsoriatic and anti-inflammatory studies of Berberis aristata extract loaded nanovesicular gels. Pharmacognosy magazine. 2017 Oct;13(Suppl 3):S587.
9. Nimisha, Fatima Z, Kaur CD, Rizvi DA. Berberine Chloride Dihydrate Enthused Nanovesicles for the Management of Dermatitis Nanovesicles for Dermatitis. Nanoscience and Nanotechnology-Asia. 2020. 10: 1. DOI : 10.2174/2210681210666200313123550
10. Nimisha, Fatima Z, Kaur CD. A review on potential of novel vesicular carriers for carrying herbal drugs in the treatment of dermatological disorders. Journal of Atoms and Molecules. 2016 May 1;6(3):987.
11. Pandey K, Nimisha. An Overview on Promising Nanotechnological Approaches for the Treatment of Psoriasis. Recent Patents on Nanotechnology. 2020. 14:1. DOI https://doi.org/10.2174/1872210514666200204 124130
12. Nimisha, Singh A, Chaubey R; Enhancement of Dissolution Rate of Quercetin using Solid Dispersion Approach: In vitro and In vivo Evaluation, Nanoscience and Nanotechnology-Asia. 2019.9:1. DOI : 10.2174/2210681209666190919095128
13. Xu D, Hu MJ, Wang YQ, Cui YL. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules. 2019 Jan;24(6):1123.
14. Karuppagounder V, Arumugam S, Thandavarayan RA, Sreedhar R, Giridharan VV, Watanabe K. Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis. Drug discovery today. 2016 Apr 1;21(4):632-9.
15. Nimisha, Singh A, Chaubey R; Enhancement of Dissolution Rate of Quercetin using Solid Dispersion Approach: In vitro and In vivo Evaluation, Nanoscience and Nanotechnology-Asia,10(3);330-349, 2020.
16. Kalpana Pandey and Nimisha*, “An Overview on Promising nanotechnological Approaches for the Treatment of Psoriasis”, Recent Patents on Nanotechnology (2020)
17. Nimisha Srivastava, Zeeshan Fatima*, Chanchal Deep Kaur and Dilshad Ali Rizvi, “Berberine Chloride Dihydrate Enthused Nanovesicles for the Management of Dermatitis Nanovesicles for Dermatitis”, Nanoscience and Nanotechnology-Asia (2020) 10: 1.
18. Nimisha, Zeeshan Fatima, Chanchal Deep Kaur, Formulation and Performance Evaluation of Berberis Aristata Extract Loaded Ethosomal Gel, Asian journal of pharmaceutics, 2017, 11(3), 176-183,.
19. Nimisha, Zeeshan Fatima, CD Kaur, A Review on Potential of Novel Vesicular Carriers for carrying Herbal drugs in the treatm
20. ent of Dermatological Disorders, J. Atoms and Molecules 6(3), 2016 ,987 – 1003.
21. W. Thomson, C. A. Bonham, and A. Zeevi, “Mode of action of tacrolimus (FK506): molecular and cellular mechanisms,” Therapeutic Drug Monitoring, vol. 17, no. 6, pp. 584–591, 1995.
22. J. Wohlrab, “Calcineurin inhibitors for topical therapy in psoriasis,” Der Hautarzt, vol. 57, no. 8, pp. 685–689, 2006.
23. Alam MS, Ali MS, Alam N, Alam MI, Anwer T, Imam F, Ali MD, Siddiqui MR and Shamim M. Design and characterization of nanostructure topical gel of betamethasone dipropionate for psoriasis. J. Appl. Pharm. Sci. (2012) 2: 148-158.
24. Alam MS, Ali MS, Alam N, Siddiqui MR, Shamim M and Safhi MM. In-vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis. Drug Invent. Today (2013) 5: 8-12.
25. Zulfakar H, Abdelouahab N and Heard CM. Enhanced topical delivery and ex-vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil. Inflamm. Res. (2010) 59: 23-30.
26. Holm EA, Esmann S and Jemec GB. Does visible atopic dermatitis affect quality of life more in women than in men? Gen. Med. (2004) 1: 125-30.
27. Ali MS, Alam MS, Alam N, Alam MI, Imam F and Ali MD. Formulation, characterization and in-vivo study of nanoemulsion topical gel of beclomethasone dipropionate for psoriasis. World J. Pharm. Pharm. Sci. (2012) 1: 839-857.
28. Warino L, Balkrishnan R and Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J. Drugs Dermatol. (2006) 5: 527-32.
29. Ashurst PJ, Caldwell IW, Champion RH, Hall-Smith SP and Milne JA. Beclomethasone dipropionate compared with betamethasone-17-valerate in the treatment of inflammatory dermatoses. Br. J. Clin. Pract. (1970) 24: 45-47.
30. Mou D, Chen H, Du D, Mao C, Xu H and Yang X. Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int. J. Pharm. (2008) 353: 270-6.
31. Seidenari S, Di NA and Giannetti A. Assessment of topical corticosteroid activity on experimentally induced contact dermatitis: echographic evaluation with binary transformation and image analysis. Skin Pharmacol. (1993) 6: 85 - 91.
32. Prasad Verma PR, Chandak AR. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance. Acta Pharm 2009;59:171–186.
33. Betageri G, Habib M. Liposomes as drug carriers. Pharm Eng 1994;14:76–77.
34. Handjani-Vila RM, Ribier A, Rondot B, Vanlerberghie G. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int j Cosmet Sci 1979;1:303–314.
35. Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes–non-ionic surfactant vesicles. j Pharm Pharmacol 1985;37:863–868.
36. Uchegbu IF. Some aspects of the niosomal delivery of doxorubicin. Ph.D. Thesis, University of London, England, 1994.
37. Hofland HE, van der Geest R, Bodde HE, Junginger HE, Bouwstra JA. Estradiol permeation from nonionic surfactant vesicles though human stratum corneum in vitro. Pharm Res 1994;11:659–664.
38. Van Hal DA, Bouwstra JA, Van Rensen A, Jeremiasse E, De Vringer T, Junginger HE. Preparation and characterization of nonionic surfactant vesicles. J Coll Interf Sci 1996;178:263–273.
39. M. H. A. Rustin, “The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review,” British Journal of Dermatology, vol. 157, no. 5, pp. 861–873, 2007.
40. R. M. Kudla, “Topical ointment,” US Patent. 4279901, 1979.
41. E. Touitou, N. Dayan, L. Bergelson, B. Godin, and M. Eliaz, “Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties,” Journal of Controlled Release, vol. 65, no. 3, pp. 403–418, 2000.
42. E. Touitou, B. Godin, N. Dayan, C. Weiss, A. Piliponsky, and F. Levi-Schaﬀer, “Intracellular delivery mediated by an ethosomal carrier,” Biomaterials, vol. 22, no. 22, pp. 3053– 3059, 2001.
43. B. Godin and E. Touitou, “Mechanism of bacitracin perme- ation enhancement though the skin and cellular membranes from an ethosomal carrier,” Journal of Controlled Release, vol. 94, no. 2-3, pp. 365–379, 2004.
44. X. Li, X. Li, Y. Zhou et al., “Development of patch and spray formulations for enhancing topical delivery of sinomenine hydrochloride,” Journal of Pharmaceutical Sciences, vol. 99, no. 4, pp. 1790–1799, 2010.
45. L. Kikwai, R. J. Babu, R. Prado et al., “In vitro and in vivo evaluation of topical formulations of Spantide II,” AAPS PharmSciTech, vol. 6, no. 4, article 71, pp. E565–E572, 2005.
46. J. du Plessis, C. Ramachandran, N. Weiner, and D. G. Mu¨ller, “The influence of particle size of liposomes on the deposition of drug into skin,” International Journal of Pharmaceutics, vol. 103, no. 3, pp. 277–282, 1994.
47. D. D. Verma, S. Verma, G. Blume, and A. Fah, “Particle size of liposomes influences dermal delivery of substances into skin,” International Journal of Pharmaceutics, vol. 258, no. 1-2, pp. 141–151, 2003.
48. Shafaque Asif, Gurjeet Kaur, Usha Pendurthi, Vineet Awasthi, Papain-mediated reduction of MTT is an artifact but not an indicator of cell apoptosis in Saccharomyces cerevisiae, JAPS. 9 (2019) 119–124. doi:https://doi.org/10.7324/JAPS.2019.90917.
49. W.Brand-Williams, M.E.Cuvelier, C.Berset, Use of a free radical method to evaluate antioxidant activity, Food chemistry. 28(1995) 25-30. doi:https://doi.org/10.1016/S0023-6438(95)80008-5
50. Rahman I, Kode A, Biswas SK, Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method, Nature protocols.1(2006) 3159–3165. doi:https://doi.org/10.1038/nprot.2006.378.
51. Beers RF JR, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952 Mar; 195(1):133-40.
52. J. Wohlrab, “Calcineurin inhibitors for topical therapy in pso- riasis,” Der Hautarzt, vol. 57, no. 8, pp. 685–689, 2006.
53. B. Fleischer Jr., W. Abramovits, D. Breneman, and E. Jaracz, “Tacrolimus ointment is more eﬀective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis,” Journal of Dermatological Treatment, vol. 18, no. 3, pp. 151–157, 2007.
54. Ana U, Pal S, Mohanta GP, Manna PK, Manavalan R. Nanoparticles: A Potential Approach for Drug Delivery. Research Journal of Pharmacy and Technology. 2011;4(7):1016-9.
55. Kumar P, Jacob J, Ajina K. Spectroscopic Estimation of Tenofovir Alafenamide, an antiretroviral drug. Research Journal of Pharmacy and Technology. 2016 May 1;9(5):538.
56. Bala R, Madaan R, Arora S. Green Synthesis and Characterization of silver nanoparticles using Kinnowmandarian peels extract and its application in Shampoo Formulation. Research Journal of Pharmacy and Technology. 2017;10(8):2461-6.